Pages that link to "Q46264670"
Jump to navigation
Jump to search
The following pages link to Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial (Q46264670):
Displaying 50 items.
- The Impact of Insulin Pump Therapy on Glycemic Profiles in Patients with Type 2 Diabetes: Data from the OpT2mise Study (Q30985130) (← links)
- Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12-month data from the OpT2mise randomized trial (Q31043511) (← links)
- Do We Need Updated Guidelines on the Use of Insulin Pump Therapy in Type 2 Diabetes? A Review of National and International Practice Guidelines (Q36130870) (← links)
- Use of V-Go® Insulin Delivery Device in Patients with Sub-optimally Controlled Diabetes Mellitus: A Retrospective Analysis from a Large Specialized Diabetes System (Q36360070) (← links)
- Blood Glucose Fluctuations in Type 2 Diabetes Patients Treated with Multiple Daily Injections (Q36453667) (← links)
- Effects of analogue insulin in multiple daily injection therapy of type 2 diabetes on postprandial glucose control and cardiac function compared to human insulin: a randomized controlled long-term study (Q36469075) (← links)
- Adaptability of structured forms for CSII initiation in patients with type 2 diabetes the Getting2Goal(SM) concept (Q36908268) (← links)
- Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics. (Q37275651) (← links)
- Continuous Glucose Monitoring in Newly Diagnosed Type 2 Diabetes Patients Reveals a Potential Risk of Hypoglycemia in Older Men. (Q37657399) (← links)
- Efficacy of a Tubeless Patch Pump in Patients With Type 2 Diabetes Previously Treated With Multiple Daily Injections (Q37732200) (← links)
- Banting Memorial Lecture 2014* Technology and diabetes care: appropriate and personalized (Q38262799) (← links)
- Clinical outcomes of adult inpatients treated with continuous subcutaneous insulin infusion for diabetes mellitus: a systematic review (Q38374958) (← links)
- New forms of insulin and insulin therapies for the treatment of type 2 diabetes (Q38519075) (← links)
- Multiple Daily Injections OR Insulin Pump Therapy: Choosing the Best Option for Your Patient-An Evidence-based Approach. (Q38580509) (← links)
- Moving toward the ideal insulin for insulin pumps (Q38631154) (← links)
- Intensive insulin therapy combined with metformin is associated with reduction in both glucose variability and nocturnal hypoglycaemia in patients with type 2 diabetes. (Q38727756) (← links)
- Determining starting basal rates of insulin infusion for insulin pump users: a comparison between methods (Q38804719) (← links)
- The role of insulin pump therapy for type 2 diabetes mellitus (Q38836724) (← links)
- Use of GLP-1 receptor agonists for type 2 diabetes treatment intensification after basal insulin failure (Q39255311) (← links)
- Response to comment on Home et al. Insulin therapy in people with type 2 diabetes: opportunities and challenges? Diabetes care 2014;37:1499-1508. (Q42360595) (← links)
- Reductions in A1C with pump therapy in type 2 diabetes are independent of C-peptide and anti-glutamic acid decarboxylase antibody concentrations (Q42949418) (← links)
- Factors associated with improved glycemic control following continuous subcutaneous insulin infusion therapy in patients with type 2 diabetes uncontrolled with bolus-basal insulin regimens: An analysis from the OpT2mise randomized trial. (Q46171850) (← links)
- Complex Assessment of Metabolic Effectiveness of Insulin Pump Therapy in Patients with Type 2 Diabetes Beyond HbA1c Reduction (Q46186192) (← links)
- Young onset type 2 diabetic patients might be more sensitive to metformin compared to late onset type 2 diabetic patients. (Q47099550) (← links)
- Impact of improving postprandial glycemic control with intensifying insulin therapy in type 2 diabetes (Q47443616) (← links)
- Keeping Up with the Diabetes Technology: 2016 Endocrine Society Guidelines of Insulin Pump Therapy and Continuous Glucose Monitor Management of Diabetes (Q49887494) (← links)
- Hypoglycaemia in type 1 diabetes: technological treatments, their limitations and the place of psychology. (Q50104167) (← links)
- A randomized controlled trial-based algorithm for insulin-pump therapy in hyperglycemic patients early after kidney transplantation. (Q52666804) (← links)
- Diabetes: insulin pump therapy for type 2 diabetes mellitus. (Q53476180) (← links)
- Continuous subcutaneous insulin infusion for type 2 diabetes. (Q53509200) (← links)
- Factors affecting the benefit of insulin dose intensification in people with Type 2 diabetes: an analysis from the OpT2mise randomized trial. (Q54437262) (← links)
- A qualitative study exploring patients' experiences regarding insulin pump use. (Q55041968) (← links)
- Clinical Benefits Over Time Associated with Use of V-Go Wearable Insulin Delivery Device in Adult Patients with Diabetes: A Retrospective Analysis. (Q55279421) (← links)
- Metformin add-on continuous subcutaneous insulin infusion on precise insulin doses in patients with type 2 diabetes. (Q55447873) (← links)
- U500 Disposable Patch Insulin Pump: Results and Discussion of a Veterans Affairs Pilot Study (Q58554365) (← links)
- Insulin Pump in Difficult to Control Type 2 Diabetes: A Single Center, Five Years' Experience (Q58563729) (← links)
- Human Regular 500 units/mL Insulin Therapy: A Review of Clinical Evidence and New Delivery Options (Q58590525) (← links)
- A Randomized Trial of Insulin Glargine plus Oral Hypoglycemic Agents versus Continuous Subcutaneous Insulin Infusion to Treat Newly Diagnosed Type 2 Diabetes (Q58699251) (← links)
- Male Patients with Longstanding Type 2 Diabetes Have a Higher Incidence of Hypoglycemia Compared with Female Patients (Q58717025) (← links)
- Insulinpumpentherapie bei Kindern, Jugendlichen und Erwachsenen (Q86376028) (← links)
- Insulin Pump Therapy - Influence on Body Fat Redistribution, Skeletal Muscle Mass and Ghrelin, Leptin Changes in T1D Patients (Q61449678) (← links)
- The Benefits and Limits of Technological Advances in Glucose Management Around Physical Activity in Patients Type 1 Diabetes (Q61813249) (← links)
- Neue Technologien in der Diabetologie (Q61911069) (← links)
- Randomized clinical trials with run-in periods: frequency, characteristics and reporting (Q64114906) (← links)
- Cost-Effectiveness of Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections in Patients with Poorly Controlled Type 2 Diabetes in Finland (Q64282683) (← links)
- Analysis of "Laboratory and Benchtop Performance of a Mealtime Insulin Delivery System" (Q64331324) (← links)
- Advances in Care for Insulin-Requiring Patients Without Closed Loop. (Q64946118) (← links)
- The OPT2MISE Study - A Review of the Major Findings and Clinical Implications (Q88312351) (← links)
- Analyzing the Potential of Advanced Insulin Dosing Strategies in Patients With Type 2 Diabetes: Results From a Hybrid In Silico Study (Q88432501) (← links)
- Improved glycaemic control and treatment satisfaction with a simple wearable 3-day insulin delivery device among people with Type 2 diabetes (Q89059864) (← links)